Propagermanium and irbesartan: Interim Phase II data

By | Oct 24, 2016 | 7:00 AM GMT

Interim data from 11 CKD patients with proteinuria who completed the 90 mg dose level in the dose-escalation part A

Read the full 204 word article

How to gain access

Continue reading with a
two-week free trial.